Atlas Brown Inc. lowered its stake in shares of AXT Inc (NASDAQ:AXTI – Free Report) by 19.2% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 31,650 shares of the semiconductor company’s stock after selling 7,500 shares during the quarter. Atlas Brown Inc.’s holdings in AXT were worth $1,803,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Brookstone Capital Management bought a new position in shares of AXT in the first quarter worth about $689,000. SG Americas Securities LLC bought a new stake in shares of AXT during the first quarter valued at approximately $108,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of AXT in the fourth quarter valued at approximately $2,939,000. XTX Topco Ltd increased its holdings in shares of AXT by 173.7% in the fourth quarter. XTX Topco Ltd now owns 35,201 shares of the semiconductor company’s stock valued at $576,000 after purchasing an additional 22,338 shares in the last quarter. Finally, SummitTX Capital L.P. bought a new position in AXT in the 4th quarter worth approximately $228,000. Institutional investors and hedge funds own 49.52% of the company’s stock.
AXT Stock Performance
AXTI opened at $92.44 on Tuesday. The firm’s fifty day moving average is $97.46 and its two-hundred day moving average is $53.62. The firm has a market cap of $6.05 billion, a PE ratio of -298.18 and a beta of 1.80. AXT Inc has a twelve month low of $1.80 and a twelve month high of $143.16.
Insiders Place Their Bets
In other AXT news, Director Jesse Chen sold 13,000 shares of the stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $95.77, for a total value of $1,245,010.00. Following the completion of the sale, the director directly owned 56,447 shares in the company, valued at $5,405,929.19. This represents a 18.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director David C. Chang sold 8,333 shares of the firm’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $111.17, for a total value of $926,379.61. Following the sale, the director directly owned 65,165 shares in the company, valued at approximately $7,244,393.05. This represents a 11.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 251,636 shares of company stock worth $27,789,677. Corporate insiders own 5.97% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on AXTI shares. Northland Securities set a $125.00 price objective on AXT in a report on Wednesday, June 3rd. Weiss Ratings raised AXT from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, May 27th. Two equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $43.80.
View Our Latest Stock Analysis on AXT
AXT Profile
AXT, Inc (NASDAQ: AXTI) is a global supplier of compound and single-element semiconductor substrates, offering a range of materials critical for high-performance electronic and optoelectronic devices. Founded in 1986 and headquartered in Fremont, California, AXT specializes in the development, manufacture and distribution of wafers composed of gallium arsenide (GaAs), indium phosphide (InP), gallium nitride (GaN) and other compound semiconductor materials. These substrates serve as the foundational platforms for devices used in data communications, wireless infrastructure, advanced computing, consumer electronics and photovoltaic applications.
AXT’s product portfolio encompasses a variety of wafer sizes, dopant concentrations and crystal orientations, tailored to meet the precise specifications of its customers.
Featured Articles
- Five stocks we like better than AXT
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Want to see what other hedge funds are holding AXTI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AXT Inc (NASDAQ:AXTI – Free Report).
Receive News & Ratings for AXT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXT and related companies with MarketBeat.com's FREE daily email newsletter.
